Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse.

The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance.

Based on WHO, Unicef guidelines, the draft policy with a roadmap for 2030, has been submitted to Yogi cabinet for approval

Dengue has become a major public health problem in Sri Lanka with a considerable economic burden.

Order of the Delhi High Court in the matter of Aditya Bhatia Vs Union of India & Others dated 15/04/2019 regarding permission to avail “Human Embryonic Stem Cell Therapy” being provided to the petitoner (Aditya Bhatia) by Nutech Mediworld.

Healthcare experts from India and the UK gathered for a first-of-its-kind conference in Birmingham to explore opportunities emerging after the Indian government's Ayushman Bharat initiative.

Union Health Secretary Preeti Sudan Sunday stressed on the partnerships with all stakeholders including doctors, paramedics, frontline health workers and community partners for achieving the goal o

NEW DELHI: Raising concerns over low penetration of health insurance, especially in the hinterland, and high ‘out of pocket’ expenditure on health, the insurance regulator has urged private insuran

The Insurance Regulatory and Development Authority of India (Irdai) released draft guidelines on standardisation of individual health products.

The revolution in hepatitis C virus (HCV) treatment through the development of direct-acting antivirals (DAAs) has generated international interest in the global elimination of the disease as a public health threat. In 2017, this led WHO to establish elimination targets for 2030.

Pages